Raquel Izumi
Gründer bei VINCERX PHARMA, INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Raquel Izumi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VINCERX PHARMA, INC. | Direktor/Vorstandsmitglied | 23.12.2020 | - |
| Geschäftsführer | 23.12.2020 | - | |
| Gründer | 19.12.2018 | - | |
| Präsident | 06.01.2021 | - | |
| Unternehmenssekretär | 23.12.2020 | - | |
LifeSci Acquisition III Corp.
 LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - |
Karriereverlauf von Raquel Izumi
Ehemalige bekannte Positionen von Raquel Izumi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Vincera Pharma, Inc. /Old/
 Vincera Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Vincera Pharma, Inc. operates as a biopharmaceutical company. It develops and delivers medicines to patients. The company was founded by Ahmed Hamdy, Raquel Izumi, Tom Thomas, Stuart Hwang, and John Byrd and is headquartered in Santa Clara, CA. | Direktor/Vorstandsmitglied | - | 01.12.2020 |
| Geschäftsführer | - | 01.03.2019 | |
| Gründer | - | 01.12.2020 | |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Gründer | 01.02.2013 | 01.05.2020 |
| Corporate Officer/Principal | 01.02.2013 | 01.05.2020 | |
| Aspire Therapeutics LLC | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2011 | 01.02.2013 |
| Gründer | 01.06.2011 | 01.02.2013 | |
| PHARMACYCLICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2010 | 01.05.2011 |
Ausbildung von Raquel Izumi
| University of California, Los Angeles | Doctorate Degree |
| University of California, Santa Barbara | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Niederlande | 2 |
Operativ
| Founder | 4 |
| Director/Board Member | 3 |
| Chief Operating Officer | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VINCERX PHARMA, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Vincera Pharma, Inc. /Old/
Vincera Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Vincera Pharma, Inc. operates as a biopharmaceutical company. It develops and delivers medicines to patients. The company was founded by Ahmed Hamdy, Raquel Izumi, Tom Thomas, Stuart Hwang, and John Byrd and is headquartered in Santa Clara, CA. | Health Technology |
| Aspire Therapeutics LLC | |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Finance |
- Börse
- Insiders
- Raquel Izumi
- Erfahrung
